Celltrion Inc
KRX:068270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Celltrion Inc (068270) under the Base Case is KRW per share.
Compared with the current market price of 215 000 KRW, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Celltrion Does
Celltrion makes prescription biologic medicines, especially biosimilars, which are follow-on versions of complex drugs made from living cells. Its products are used in areas like immune disease, cancer, and other serious conditions, and they are sold to hospitals, clinics, distributors, and public health systems through its own sales network and partner companies.
- Headquarters
- Korea KR
- IPO date
- Jul 19, 2005
Celltrion has a narrow economic moat
Patents protecting Celltrion’s self-injected treatment Zymfentra limit direct copying, while its specialized manufacturing processes make competing on production costs harder for smaller entrants. These protections support its profits without shielding its broader range of medicines from established competitors.
Read the full moat analysisBalance Sheet
Continue Research
Decided on Celltrion? Get an email when Celltrion Inc reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one Celltrion Inc stock?
The intrinsic value for
Celltrion Inc (068270) under the Base Case is KRW.
Is Celltrion Inc stock undervalued or overvalued?
Compared with the current market price of 215 000 KRW, the stock appears .